Analyst Reco. DiaSorin S.p.A.

Stocks

DIA

IT0003492391

Medical Equipment, Supplies & Distribution

Real-time Borsa Italiana Other stock markets 12:08:13 12/06/2026 BST			5-day change	1st Jan Change
68.58 ^EUR	+0.12%		-3.98%	-0.06%

06-11	Piper Sandler Begins Diasorin Coverage with Neutral Rating	MT
06-08	MPS catalyzes banking M&A wave and drives MIB higher	AN

Analyst Reco.

06-11	Piper Sandler Begins Diasorin Coverage with Neutral Rating	MT
05-21	DiaSorin: Soft start, loaded H2
05-11	DiaSorin: Tough quarter, but margins beat and guidance stood firm
04-09	UBS Downgrades DiaSorin to Neutral Rating, Cuts PT	MT
03-24	Invest Securities Downgrades DiaSorin to Neutral Rating, Cuts PT	MT
03-23	DiaSorin: Lackluster 2026 guidance and execution uncertainty spook investors
03-23	Mediobanca Downgrades Diasorin to Neutral Rating, Cuts PT	MT
03-23	Equita SIM Downgrades Diasorin to Hold, Cuts PT	MT
12-31	AlphaValue/Baader Europe Lowers DiaSorin's PT, Keeps at Buy	MT
12-30	AlphaValue/Baader Europe Cuts Diasorin Price Target, Forecasts Amid Challenges to Near-term Earnings	MT
12-30	DiaSorin trims outlook amid market headwinds
11-27	Intesa Sanpaolo Upgrades Diasorin to Buy, Cuts PT	MT
11-07	Deutsche Bank Downgrades Diasorin to Hold, Cuts PT	MT
11-06	DiaSorin share slump after Q3 earnings miss
11-06	Banca Akros Downgrades Diasorin to Accumulate, Cuts PT	MT
31/10/25	DiaSorin receives FDA authorization for Covid and influenza detection kit	AN
12/09/25	DiaSorin: The sky looks clearer for DiaSorin
27/08/25	JP Morgan Begins Diasorin's Coverage at Underweight	MT
26/08/25	Morgan Stanley Upgrades Diasorin to Overweight, Lifts PT	MT
14/08/25	RBC Capital Upgrades DiaSorin to Outperform	MT
01/08/25	DiaSorin: Decent Q2 performance; 2025 guidance unchanged
07/05/25	DiaSorin: Slight Q1 beat with 2025 guidance remaining unchanged
10/04/25	Kepler Cheuvreux Upgrades DiaSorin to Hold, Boosts PT	MT
17/03/25	DiaSorin: Slight Q4 miss but the 2025 outlook was encouraging
11/02/25	Deutsche Bank Begins Diasorin's Coverage at Buy	MT